跳到正文
原文
Medical Xpress·· 29 天前AI 评分38

AAO会议探讨GLP-1受体激动剂与年龄相关性黄斑变性的关联

AAO: Association between GLP-1 receptor agonists and age-related macular degeneration explored

AI 导读

在AAO年会上公布的一项病例对照分析显示,在未校正混杂因素时,GLP-1受体激动剂使用与年龄相关性黄斑变性(AMD)相关联的粗比值比高于1;但在调整2型糖尿病、高血压或高脂血症后,比值比方向发生逆转。基于超过3亿患者数据的这项研究并未证实GLP-1类药物独立增加AMD风险,研究者希望此结果能鼓励未来更严谨的研究纳入基础疾病考量。

正文
eye exam
Credit: José Antonio Otegui Auzmendi from Pexels

Crude odds ratios suggest an increased risk for age-related macular degeneration (AMD) in association with glucagon-like peptide-1 receptor agonist (GLP-1 RA) use, but this finding is reversed after adjustment for cardiometabolic confounding variables, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held Oct. 9 to 12 in New Orleans.

Franklin Ye Ruan, from the Carle Illinois College of Medicine in Urbana, and colleagues examined the association between GLP-1 RA use and AMD in a case-control analysis of more than 300 million patients from Epic Cosmos, controlling for confounding clinical covariates.

Overall, 15,385,073 of the 300,410,753 patients had GLP-1 RA exposure, 1,384,467 had AMD and 115,056 patients had both. The researchers found that the crude odds ratios for any AMD, dry AMD and wet AMD were 1.68, 1.89 and 1.53, respectively.

The direction of the odds ratios was reversed with Mantel-Haenszel adjustment after accounting for type 2 diabetes mellitus (odds ratios, 0.69 and 0.62 for any and wet AMD, respectively), hypertension (odds ratios, 0.65 and 0.59 for any and wet AMD) or hyperlipidemia (odds ratios, 0.63 and 0.57 for any and wet AMD). For wet AMD, the reversal was most pronounced. Odds ratios were attenuated to 1.17 with adjustment for body mass index, and age was associated with an increase in odds ratios to 1.94.

"Our hope is that these findings encourage more rigorous studies on GLP-1 medications and macular degeneration, taking other underlying health conditions into account," Ruan said in a statement.

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

© 2026 HealthDay. All rights reserved.

Citation: AAO: Association between GLP-1 receptor agonists and age-related macular degeneration explored (2026, October 21) retrieved 21 October 2026 from https://medicalxpress.com/news/2026-10-aao-association-glp-receptor-agonists.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com